Macrophage Therapeutics, Inc.
Research - Englewood Cliffs, New Jersey, United States
Macrophage Therapeutics, Inc. Employees
Macrophage Therapeutics, Inc. Details
Macrophage Therapeutics (MT) is developing novel targeted anti-inflammatory and immuno-oncology therapeutics based on its proprietary Activated Macrophage targeting platform.MT is leveraging its unique CD206 receptor-based delivery system to deliver proven therapeutics in a more precise and targeted fashion. With binding affinities 10,000X today's best antibodies MT's approach eliminates off-target toxicity and increases the efficacy of proven therapeutic agents. MT's CD206 targeting platform is already clinically established and being used in an FDA/EMEA approved radiopharmaceutical.
Macrophage Therapeutics, Inc. Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly
Hosting
Amazon AWS